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ABSTRACT 
Objective: This study aimed to determine Indonesian native stingless bee propolis from ten provinces of Indonesia as complementary nutraceutical 
candidate of anti-tuberculosis drug (ATD).  
Methods: Propolis samples were collected from stingless bee cultivated in ten provinces of Indonesia. The antioxidant capacity test was performed 
using 2,2-diphenyl-1-picrylhydrazyl and toxicity test was done using Brine Shrimp Lethality Test. The inhibition test of Mycobacterium tuberculosis 
(Mtb) was performed using Lowenstein-Jensen medium and bacterial colonies were estimated using Most Probable Number.  
Results: The highest antioxidant capacity was found in Geniotrigona incisa (G. incisa) propolis from South Sulawesi Province with an IC50 of 100.05 
ppm, while the lowest antioxidant capacity was found in Tetragonula minangkabau propolis from North Sumatera Province with an IC50 of 1378.90 
ppm. The lowest propolis toxicity was found in Geniotrigona thorasica propolis from South Kalimantan Province with an LC50 of >1000.00, while the 
highest propolis toxicity was found in Tetragonula laeviceps (T. laeviceps) propolis from Banten Province with an LC50 of<50.00. T. laeviceps propolis 
from Banten Province had the lowest Mtb inhibition, with the inhibition value of 1.59%. On the other hand, the highest inhibition was shown by 
Tetragonula biroi propolis from South Sulawesi Province and Tetragonula fuscobalteata propolis from West Nusa Tenggara Province with 100% 
inhibition value (equivalent to rifampicin). 
Conclusion: Based on all determinant parameters, G. incisa propolis from South Sulawesi Province has the highest score, and it is defined as 
complementary nutraceutical candidate of ATD. 
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Tuberculosis (TB) is a global infectious disease problem and the 
second leading cause of death after HIV/AIDS infection. Indonesia 
ranks 2nd out of 30 countries in the world in terms of TB epidemic, and 
it is categorized as a high-burden country [1]. One of the problems 
encountered in the use of the anti-tuberculosis drug (ATD) is the 
hepatotoxic effect [2, 3]. The hepatotoxic effects of ATD may cause 
decreased appetite, nausea, dizziness, insomnia, fever and weight loss 
[4, 5], thereby decreasing nutritional status of the patients, whereas 
good nutritional status strongly supports the healing process [6].  
Hepatotoxicity mechanism of rifampicin is mediated by oxidative 
damage. The antioxidant mechanism in reducing reactive oxygen 
species (ROS) is strongly suspected as a hepatoprotective 
mechanism of liver toxicity [7, 8]. Therefore, the provision of 
antioxidants is expected to reduce the hepatotoxic effects of ATD. 
Numerous studies have shown that propolis is an antioxidant and 
able to protect the liver from toxic effects of drugs and ATD [9-13]. 
Propolis also provides a great protection from the hematologic 
toxicity of rifampicin and isoniazid [14]. 
Stingless bee propolis has strong antibacterial activity [15-16], and it 
strongly inhibits Streptococcus sanguinis [17] and Streptococcus mutans 
[18]. Propolis also has the ability to fight TB infection [19]. Numerous 
studies have revealed that propolis synergizes with ampicillin, 
gentamycin, and streptomycin to kill Mycobacterium tuberculosis (Mtb) 
[20]; synergizes with streptomycin, rifampicin, isoniazid, and ethambutol 
[21]; and synergizes with streptomycin and cloxacillin [22]. Therefore, 
propolis is an ideal material as an ATD complementary nutraceutical for 
pulmonary TB healing. Administration of propolis-equipped ATD is 
expected to reduce the hepatotoxic effects in TB patients and strengthen 
the ability to fight TB infection. 
Indonesia has a large diversity of propolis sources, due to the diversity of 
bee species and vegetation of resin sources. It is therefore very 
interesting to examine biological activities (antioxidant activity, toxicity, 
and inhibition of Mtb) of propolis from various provinces in order to 
discover the propolis that is able to resist ATD toxic effects, having low 
toxicity and is able to inhibit Mtb infection. 
This study aimed to determine Indonesian native stingless bee 
propolis from ten provinces in Indonesia as complementary 
nutraceutical candidate of ATD. 
MATERIALS AND METHODS 
Propolis samples and chemicals 
Fourteen different stingless bee propolis samples were collected 
from stingless bee farm in ten provinces in Indonesia, namely 
Tetragonula minangkabau (T. minangkabau) and Tetragonula 
moorei (T. moorei) from North Sumatera Province, Tetragonula 
laeviceps (T. laeviceps) from Banten Province, T. laeviceps from West 
Java Province, T. laeviceps from Central Java Province, Heterotrigona 
itama (H. itama) from West Kalimantan Province, H. itama from East 
Kalimantan Province, H. itama, Geniotrigona thorasica (G. thorasica) 
and T. laeviceps from South Kalimantan Province, Geniotrigona incisa 
(G. incisa) and Tetragonula biroi (T. biroi) from South Sulawesi 
Province, Tetragonula fuscobalteata (T. fuscobalteata) from West 
Nusa Tenggara Province, and T. fuscobalteata from North Maluku 
Province. The chemicals used were 70% hydroethanolic extract, 2,2-
diphenyl-1-picrylhydrazyl (DPPH), methanol, dimethyl sulfoxide 
(DMSO), Trolox, and tween 80% that were obtained from 
Sigma/Aldrich Co. through distributor company in Jakarta, 
Indonesia. Rifampicin was obtained from a drugstore in Bogor, 
Indonesia. 
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Extraction of propolis 
All of the propolis samples were chopped into small pieces and 
macerated with 70% hydroethanolic extract (ratio of sample and 
ethanol = 1:3) by using water bath shaker at room temperature for 2 
d. The filtrate was collected and the residue was macerated two 
times under the same condition. After filtration, the filtrate was 
evaporated by a rotary evaporator (3 rpm at 60 °C) and then the 
pure propolis extract was collected.  
Free radical scavenging activity test-2,2-diphenyl-1-picrylhydrazyl 
(DPPH) 
The free radical scavenging activity was measured using DPPH [23]. 
Briefly, various propolis extract solutions (2 mg/ml) were added to 
2 ml of DPPH, dissolved in methanolic solution (0.1192 mmol/l), and 
maintained in the dark for 30 min at room temperature. The 
absorbance was then measured at 517 nm. Methanol was used 
instead of propolis extract solutions as a control and Trolox was 
used as a positive control. The results were expressed with IC50 
value (50% inhibitory concentration), which determined the extract 
concentration (µg/ml) that provided 50% inhibition. The lower of 
the value is the greater of the capacity of the antioxidant. The 
scavenging capacity of the DPPH radical was calculated with the 
equation below (percent inhibition of the DPPH radical). 
% Inhibition of DPPH =
Abs DPPH − Abs sample1
Abs DPPH
x 100 
The extract concentration value was plotted against the percent 
inhibition of DPPH· and the IC50 value was obtained by linear 
regression. All treatments were run in triplicate. 
Toxicity test-brine shrimp lethality test (BSLT)  
We used preliminary toxicity of BSLT by using Artemia salina Leach [24]. 
Artemia cysts were prepared by Biopharmaceutical Research Center 
(BRC), Bogor Agricultural University, Indonesia. The cysts were hatched 
in the laboratory using artificial seawater at 27–30 °C medium. 
Appropriate light, pH of 7.5-8.5, alkaline water with a salinity of 3% and 
temperature of 27-30 °C were regulated during the test. The larvae were 
collected from hatcheries with a plastic pipette for LC50 study. 
LC50 was estimated in five dilutions (250, 500, 750, 1000 and 1500 
µg/ml) of propolis extracts for 24 h. In each plate, 0.5 ml of propolis 
extract with different concentrations was added to 4.5 ml of the brine 
shrimp solution. Ten brine shrimp larvae that had been grown for 48 h 
were added to each plate. For each propolis concentration, one DMSO 
with 4.5 ml of brine shrimp solution without propolis extract was used 
as a control. The plates were sealed with their lids in the darkness at 
room temperature for 24 h. During the test, feeding and aeration were 
not allowed. After 24 h, the number of dead and surviving larvae was 
counted on the plates, and cytotoxicity of the samples was then 
determined. Each experiment was performed in triplicate. During each 
experiment, if mortality of the control group was more than 10% of the 
experiment group, the procedure must be repeated. The mortality was 
calculated using the following formula:  
Mortality =
Accumulation of death larvae 
Accumulation of death + surviving larvae
x100% 
The graph was constructed with log concentration as the x-axis and 
mortality as the y-axis. A substance was confirmed as toxic when 
LC50 of the extract was less than 1000 ppm and LC50 of the pure 
compound was less than 30 ppm. 
Mycobacterium tuberculosis inhibition test-proportion method 
Mycobacterium tuberculosis inhibition test was based on 100% 
inhibitory concentration by ATD (i.e. rifampicin). At 0.02% 
rifampicin concentration, all tests consistently showed no Mtb 
growth (100% inhibition). Hence, the concentration was used as the 
standard sample concentration. Therefore, sample concentration 
also used the same concentration. 
Suspension preparation  
Sterile screw-cap tubes were filled with 10 glass beads and 1 drop of 
0.1% tween 80%. The tubes were then weighed and recorded, for 
example, M1. Mtb H37Rv colony aged 3-6 w was taken with 
inoculating loop, inserted into the tube, then weighed again, for 
instance, M2. Weight of Mtb H37Rv = M2-M1 = M3. The tube 
contained Mtb H37Rv was vortexed into homogeneous solution and 
set aside for 10 min to let aerosol down. Sterile distilled water in M3 
mg (1 ml ∼ 1 mg) was added and homogenized using vortex for 2 
min. Finally, it was set aside until the precipitate of coarse particles 
was formed and the supernatant seemed clear. 
Inoculation 
A 100 µl supernatant was taken by automatic pipette and yellow tip 
and inserted into a threaded tube containing Lowenstein Jensen (LJ) 
medium. There were three kinds of LJ medium, namely a) LJ medium 
without rifampicin and propolis (negative control), b) LJ medium 
with rifampicin (positive control), and c) LJ medium with propolis 
sample (consisting of 14 propolis samples). Two replications of each 
inoculation were made. The supernatant (inoculation fluid) was 
flattened to cover the entire surface of the medium. 
Colony counting 
The colonies growing on the media surface in screw-cap tubes were 
counted manually with a magnifying glass. The number of colonies 
was recorded as the Most Probable Number (MPN). 
Interpretation 
The MPN on negative control was considered as 100% growth. 
Furthermore, inhibition of Mtb in propolis sample could be 
calculated by the following calculation:  
Mtb inhibition activity of the sample =  100 − % growth of Mtb 
Determination of the best candidate 
The best candidate was determined based on the total score of each 
propolis sample obtained from three parameters; i.e. antioxidant 
capacity, toxicity, and Mtb inhibition activity. Antioxidant scores were 
obtained by sequencing IC50 values of propolis samples. The smaller 
the value of IC50, the more powerful the biological activity and the 
greater the score. The lowest score was 1 and the highest score was 14 
(according to the number of propolis samples). If there were more 
than one sample having the same IC50 score, the same score was given 
so that the highest score was less than 14. Inhibition score of Mtb was 
obtained by sequencing the inhibition value (%). The greater the 
inhibition percentage (%), the greater the score. If more than one 
sample had the same inhibition percentage (%), the same score was 
given so that the highest score was less than 14. The toxicity score was 
obtained from LC50 value. The smaller the LC50 value, the greater the 
toxicity. The desired propolis was the one with low toxicity. The 
greater the toxicity, the smaller the score. The method to sort the 
scores was similar to the determination of other parameter scores. 
Referring to hepatotoxicity problem in the use of ATD in TB 
treatment, the desired nutraceutical propolis was the one which has 
a strong hepatoprotective activity to reduce the hepatotoxic effects 
of ATD. Rifampicin hepatotoxicity mechanism is mediated by 
oxidative damage [7], and antioxidant mechanism in reducing ROS is 
strongly suspected as a hepatoprotective mechanism of liver toxicity 
[8,25]. Therefore, the antioxidant capacity of the sample became the 
main parameter and had the greatest weight. Additionally, the 
determination of propolis as the complementary of ATD also 
considered patient safety (low toxicity) and Mtb inhibition ability 
that could strengthen ATD to fight infection. The weight distribution 
of determinant parameters was presented in the following table:
  
Table 1: Determinant parameters and their weighting 
Parameter Weighting (%) 
Antioxidant capacity 50 
Mtb inhibition activity 25 
Toxicity 25 
Total 100 
Propolis sample that obtained the highest total score was defined as a complementary nutraceutical candidate of ATD. 
Sulaeman et al. 
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RESULTS AND DISCUSSION 
Antioxidant capacity 
Antioxidant capacity was indicated by IC50 value. The greater the IC50 
value, the weaker the antioxidant activity. Conversely, the lower the 
IC50 value, the more powerful the antioxidant activity. This study 
showed that T. minangkabau propolis from North Sumatera 
Province had the weakest antioxidant capacity (IC50 of 1378.95 
ppm), whereas G. incisa propolis from South Sulawesi Province had 
the strongest antioxidant capacity (IC50 of 100.05 ppm).  
The difference in antioxidant capacity of propolis might be due to the 
difference in the composition of the active compounds in it. The more the 
active compounds that have antioxidant properties and the stronger the 
activity, the stronger the antioxidant capacity of a propolis. This 
assumption is strengthened by the results of the previous study which 
has suggested that propolis with different phytochemical composition 
produces different antioxidant capacity [23].  
The strength of propolis’s antioxidant capacity is influenced by two 
factors. The first one is the bee species differences; i.e. different bee 
species have different tastes on plant resins. In this study, G. incisa 
propolis and T. biroi propolis came from the same farm with the 
availability of the same resin source plant. However, both propolis 
had different antioxidant capacities. These findings strengthen the 
opinion that each bee species has a unique and different behaviour 
from other bee species [26]. The second one is the difference in resin 
source plant. Each plant resin has a unique and distinctive active 
compound composition between plant species. The difference is 
very influential on the composition of the active compounds 
contained in the plant and on its antioxidant capacity. Silymarin is a 
phytochemical that has an antioxidant activity and is an excellent 
hepatoprotector [27, 28], propolin G has a strong anticancer activity 
[29], glycosides have strong anti Mtb [30], and quercetin has strong 
antioxidant and antitumor activities [31].  
The strength of the antioxidant capacity of G. incisa bee propolis is 
associated with the number of medicinal plants that become its resin 
sources. The plants are kaju landong (Paraserianthes falcataria), 
palili (Lithocarpus celebica Rehder), annaja (Saurauia costata), 
poringan (Baccaurea sp), uru (Arenga pinnata), and sempur (Dillenia 
indica). These plants are known as medicinal plants by local people. 
G. incisa bees also take resin from food plants, namely mango 
(Mangifera indica) and durian (Durio ziberthinus). 
Related to antioxidant function, hepatotoxicity mechanism of 
rifampicin is mediated by oxidative damage [7, 32]. Isoniazid also 
causes liver damage and it can be reduced by strong antioxidant 
compounds [25]. The silymarin (a plant phytochemical compound 
with strong antioxidant activity) has been proven to protect the liver 
from toxic effects of isoniazid, rifampicin, and pyrazinamide and has 
low toxicity [27]. 
 
Table 2: Antioxidant capacity of stingless bee propolis samples from different provinces 
Province origin Bee Species  IC50 Antioxidant capacity (ppm)a Score order Weighting score (50%) 
North Sumatera  T. minangkabau 1378.95±16.67 1 0.5 
North Sumatera  S. moorei 208.92±9.57 12 6.0 
Banten T. laeviceps 150.83±0.21 13 6.5 
West Java  T. laeviceps 574.85±4.49 6 3.0 
Central Java T. laeviceps 283.05±20.44 9 4.5 
West Kalimantan  H. itama 227.54±9.32 10 5.0 
East Kalimantan  H. itama 939.98±6.51 2 1.0 
South Kalimantan  H. itama 636.61±11.28 4 2.0 
South Kalimantan T. laeviceps 580.40±8.61 5 2.5 
South Kalimantan G. thorasica 905.06±7.96 3 1.5 
South Sulawesi  G. incisa 100.05±13.02 14 7.0 
South Sulawesi  T. biroi 467.93±20.58 8 4.0 
West Nusa Tenggara  T. fuscobalteata 477.88±7.62 7 3.5 
North Maluku  T. fuscobalteata 218.65±3.00 11 5.5 
amean±SD, n = 3.  
 
Numerous studies have indicated that antioxidant mechanisms in 
suppressing radical oxygen species (ROS) are strongly suspected to be 
a hepatoprotective mechanism of liver toxicity [8, 33, 34]. Propolis 
extract also has a hepatoprotective effect against oxidative stress [35, 
36]. Furthermore, murine β TC-6 cell lines incubated with toxicants 
have increased thiobarbituric acid reactive substances (TBARs), 
decreased glutathione (GSH) concentrations and cell viability, and 
increased cell apoptosis. On the other hand, the lowered TBARs 
increased GSH concentrations, increased cell viability and reduced cell 
apoptosis were found in cells incubated with propolis extract.  
Various research results have shown that propolis is able to protect 
the liver from mercury exposure [37] and aluminium toxicity 
exposure [38] through an antioxidant mechanism. It also protects 
the liver from the toxic effects of atorvastatin [38], ethylene glycol 
[39], and cypermethrin [40]. Propolis extract (150 mg/kg) has been 
proven to have the good hepatoprotective ability in isoniazid-
induced hepatotoxicity in male albino mice [41]. 
However, the previous study confirmed that the results of plasma 
antioxidant measurements as a parameter of in vivo oxidative 
damage in mini pig were not aligned with the results found in rats 
[42]. Therefore, it was highly probable that in vitro, in vivo and 
clinical measurements of antioxidants were not always aligned. 
However, various results of the above studies can be the basis for us 
to establish that antioxidant capacity is an important criterion and is 
associated with its potential as a hepatoprotector. 
Based on antioxidant capacity, G. Incisa propolis from South 
Sulawesi Province has the strongest potential to protect the liver 
from toxic effects of ATD. 
Toxicity 
One of ATD and anti-TB regimen requirements was safe for patients 
[43]. Similarly, propolis should be safe as a complementary of ATD. The 
safety was indicated by its toxicity. Toxicity potential was indicated by 
LC50 value. The higher the LC50 value, the safer the propolis. Conversely, 
the lower the LC50 value, the stronger the propolis toxicity.  
In this examination, the test sample was liquid propolis with propylene 
glycol as a liquid filler. Therefore, propylene glycol was analyzed as a 
control. According to table 3, propylene glycol as the liquid filler had 
toxicity with an LC50 value of 652.49 ppm. Thus, the toxicity exhibited by 
propolis sample was partly derived from propylene glycol contribution. 
According to the propolis toxicity, there was an interesting fact that the 
toxicity was widespread (<50.00 to>1000.00 ppm). It means that some 
propolis have stronger toxicity than the control (652.49 ppm), while 
some of them have lower toxicity. 
These data suggested that there was an interaction possibility 
between propolis component and propylene glycol, thereby affecting 
its toxicity level. This phenomenon was very interesting to be 
learned further, in order to identify which propolis components that 
were synergetic, neutral or antagonist with propylene glycol. 
Sulaeman et al. 
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Table 3: Toxicity of stingless bee propolis samples from different provinces 
Province origin Bee species  Toxicity LC50 (ppm) a Score order Weighting score (25%) 
North Sumatera T. minangkabau 621.49±45.40 7 1.75 
North Sumatera  S. moorei 55.09±12.20 2 0.50 
Banten T. laeviceps <50.00±13.55 1 0.25 
West Java T. laeviceps 521.74±18.22 5 1.25 
Central Java T. laeviceps 615.84±21.33 6 1.50 
West Kalimantan H. itama 802.26±32.55 10 2.50 
East Kalimantan H. itama 451.32±25.35 4 1.00 
South Kalimantan H. itama 270.60±19.27 3 0.75 
South Kalimantan T. laeviceps 838.05±16.22 11 2.75 
South Kalimantan  G. thorasica >1000.00±21.76 14 3.50 
South Sulawesi G. incisa 854.75±23.82 12 3.00 
South Sulawesi  L. terminata 656.41±21.10 9 2.25 
West Nusa Tenggara T. fuscobalteata 624.34±12.98 8 2.00 
North Maluku T. fuscobalteata 932.63±10.88 13 3.25 
amean±SD, n = 3.  
 
According to table 3, the safest propolis is propolis G. thorasica from 
South Kalimantan Province, with an LC50 of more than 1000.00 
(score order is 14, weighting score is 3.5). In terms of safety, it is the 
best propolis. Conversely, the most toxic propolis is T. laeviceps 
propolis from Banten Province, with an LC50 of less than 50.00 
(score order is 1, weighting score is 0.25). 
As is the case with antioxidant capacity, the difference in the toxicity 
of propolis is influenced by bee species and plant species of resin 
sources. A study result suggested that the difference in the toxicity of 
propolis might be due to the differences in the composition of the 
active compounds it contained and each active compound had 
different toxicity levels [44]. The results of this toxicity test were 
also in line with another study which suggested that the biological 
activity and phytochemical composition were influenced by the 
geographical location and the plant origin of the resin [31].  
G. thorasica bee propolis (the lowest toxicity) is derived from the 
resin of jackfruit (Artocarpus heterophyllus), mangosteen (Garcinia 
mangostana), durian (Durio zibethinus), mango (Mangifera indica), 
and lead tree (Leucaena leucocephala). These data regarding resin 
source plant provide clues that the low toxicity of G. thorasica 
propolis is influenced by plant food resins that are usually non-toxic. 
The highest toxicity occurs in the liver, followed by brain and 
kidneys [45]. Therefore, propolis toxicity becomes one of the 
considerations in the determination of ATD complementary 
nutraceutical candidate. Numerous studies have shown that propolis 
has low liver toxicity. Behavior changes and clinical toxicity were not 
found in experimental mice receiving an ethanolic extract of propolis 
up to a dose of 2000 mg/kg body weight (BW) during a 45-d study. 
Nevertheless, there were hematological and biochemical changes at 
that dose compared to the control [46]. Another study on Swiss mice 
also showed no signs of toxicity in the propolis hydroalcoholic 
extract administration with doses of 1000, 2000 and 4000 mg/kg 
BW. No death was found in all the treatment groups, and blood 
biochemical analysis showed decreased levels of alanine 
aminotransferase (ALT) and alkaline phosphatase (ALP) indicating 
that propolis was hepatoprotective [44]. Toxic effects were 
undetectable in mice receiving 25 µl propolis/administration four 
times a day [47]. Furthermore, adult female Sprague-Dawley mice 
receiving 200 mg propolis/d orally were able to resist the toxic 
effects of oral administration of 200 mg methoxychlor/kg BW twice 
a week [48]. A review stated that LD50 of propolis in various mouse 
species ranged from 300 to 2050 mg/kg [49].  
However, we recognize that BSLT method cannot be a strong basis 
for the determination of toxicity, but these data are useful for early 
predictions of propolis toxicity. Further toxicity analysis should be 
performed on the determined candidates to establish the propolis 
that is eligible to be declared a complementary nutraceutical of ATD. 
Mycobacterium tuberculosis strain H37Rv inhibitory activity 
Various studies have revealed that propolis has the ability against Mtb 
germ and synergizes with ATD [19, 22]. Therefore, propolis ability in 
inhibiting Mtb H37Rv becomes one of the considerations in our study. 
In the present study, rifampicin with a concentration of 0.02% 
(positive control) consistently showed no colony growth of Mtb H37Rv 
or 100% inhibition. In contrast, 100% colony growth or 0% inhibition 
were found in negative control (without rifampicin or propolis). 
  
Table 4: Mycobacterium tuberculosis strain H37Rv inhibition activity of stingless bee propolis samples from different provinces 








- 0.0±0.0 0.00 100.00 - - 
Negative control - 157.5±7.5 100.00 0.00 - - 
North Sumatera T. minangkabau*) - - - - - 
North Sumatera S. moorei 106.5±1.5 67.62 32.38 6 1.50 
Banten T. laeviceps 155.0±0.0 98.41 1.59 1 0.25 
West Java T. laeviceps 150.0±0.0 95.24 4.76 3 0.75 
Central Java T. laeviceps 137.5±2.5 87.30 12.70 4 1.00 
West Kalimantan H. itama 152.5±2.5 96.83 3.17 2 0.50 
East Kalimantan H. itama 120.0±0.0 76.19 23.81 5 1.25 
South Kalimantan H. itama 150.0±0.0 95.24 4.76 3 0.75 
South Kalimantan T. laeviceps*) - - - - - 
South Kalimantan G. thorasica 35.0±5.0 22.22 77.78 8 2.00 
South Sulawesi G. incisa 79.0±11.0 50.16 49.84 7 1.75 
South Sulawesi  T. biroi 0.0±0.0 0.00 100.00 9 2.25 
West Nusa Tenggara T. fuscobalteata 0.0±0.0 0.00 100.00 9 2.25 
North Maluku T. fuscobalteata 152.5±2.5 96.83 3.17 2 0.50 
amean±SD, n = 3, *) the data were eliminated due to the failed test. 
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It was interesting that different propolis had different Mtb H37Rv 
inhibitory capability. At the same level as rifampicin, T. laeviceps 
propolis from Banten Province showed a very low inhibition of 
1.59% (score order was 1, weighting score was 0.25). Meanwhile, T. 
biroi propolis from South Sulawesi Province and T. fuscobalteata 
propolis from West Nusa Tenggara Province showed maximum 
inhibition (100%) with score order of 9 and weighting score of 2.25. 
Their abilities were equivalent to rifampicin.  
The investigation results regarding plant origin of the resin showed 
that T. fuscobalteata propolis from West Nusa Tenggara Province 
collected resin from Ceara rubber tree (Manihot glaziovii), mangosteen 
(Garcinia mangostana), mango (Mangifera indica), jackfruit 
(Artocarpus heterophyllus), cempedak (Artocarpus integer), durian 
(Durio ziberthinus), pomelo (Citrus maxima), banana (Musa spp.), and 
castor oil plant (Ricinus communis). The resin source plants were 
divided into two groups; i.e. medicinal plants and food plants. The 
medicinal plants were Ceara rubber tree (Manihot glaziovii), 
mangosteen (Garcinia mangostana), pomelo (Citrus maxima), and 
castor oil plant (Ricinus communis). Meanwhile, the food plants were 
mangosteen (Garcinia mangostana), mango (Mangifera indica), 
jackfruit (Artocarpus heterophyllus), cempedak (Artocarpus integer), 
durian (Durio ziberthinus), pomelo (Citrus maxima), and sweet orange 
(Citrus sinensis). The resin source plants of T. fuscobalteata from West 
Nusa Tenggara Province had similarities with the resin source plants 
of G. incisa propolis and T. biroi propolis from South Sulawesi that 
were dominated by medicinal plants, which had an effect on the strong 
Mtb inhibition activity. In this study, it appeared that the more the 
resins from medicinal plants, the stronger the biological activity and 
toxicity of the propolis. Conversely, the more the resins from food 
plants, the weaker the biological activity and toxicity.  
This study strengthens the results of various previous studies which 
have shown that the antimycobacterial activity of propolis varies. The 
water extract of propolis has a low Mtb H37Rv inhibitory ability [50]. 
In contrast, numerous studies have indicated that ethanol extract of 
propolis has good Mtb inhibitory ability [19-22, 31, 51, 52]. 
The difference in the inhibitory of Mtb H37Rv strengthens the 
opinion that biological activity of propolis is diverse and influenced 
by the content of its active compounds [31]. In our study, the 
differences were allegedly influenced by different species of bees 
and the origin of plant resins. 
Our study showed that T. biroi propolis from South Sulawesi and T. 
fuscobalteata propolis from West Nusa Tenggara Province were the 
best propolis in inhibiting Mtb H37Rv. However, this test had 
limitations. There were two Mtb H37Rv inhibitory data not available 
due to test failure and lack of test samples; i.e. T. minangkabau 
propolis from North Sumatera Province and T. laeviceps propolis 
from South Kalimantan Province. Both of them might have a 
stronger ability to inhibit Mtb H37Rv than other propolis. 
Determination of the best candidate 
The best candidate was determined by three determinant 
parameters; i.e. antioxidant capacity, toxicity, and inhibition of Mtb. 
Antioxidant capacity was the main criterion because the primary 
mechanism to protect the liver from the toxic effects of ATD was to 
reduce the oxidant radical of ATD metabolites. 
Moreover, additional criteria were safety (low toxicity) and having 
good ability to inhibit Mtb H37Rv. Therefore, antioxidant capacity, 
toxicity, and Mtb H37Rv inhibition were given the weight of 50%, 
25%, and 25%, respectively. The selected propolis candidate was the 
one with the highest total score. With these three criteria, the ATD-
complementary propolis was expected to have a major ability as 
hepatoprotector, as a solution of one of the main problems in the use 
of ATD. In addition, ATD-complementary propolis was also safe (not 
toxic) and having good ability to fight Mtb infection. 
The highest score was achieved by G. incisa propolis originating 
from South Sulawesi Province, with a score of 11.75. The score 
was mainly obtained from antioxidant activity (7.0), toxicity 
(3.0) and Mtb H37Rv inhibition (1.75). An antioxidant capacity 
score of this propolis was the highest compared to other 
propolis samples. Meanwhile, in terms of toxicity, this propolis 
was not the safest. There were two safer propolis samples; i.e. G. 
thorasica propolis from South Kalimantan Province with a score 
of 3.50 and T. fuscobalteata propolis from North Maluku 
Province with a score of 3.25. Likewise in the Mtb H37Rv 
inhibition, this propolis was not the strongest. There were three 
samples of propolis which had stronger Mtb inhibition; i.e. T. 
biroi propolis from South Sulawesi Province and T. fuscobalteata 
propolis from West Nusa Tenggara Province that had the same 
score (2.25), as well as G. thorasica propolis from South 
Kalimantan Province with a score of 2.00. 
 
Tabel 5: Determination of the best candidate 
Province origin Bee species Antioxidant activity Toxicity Mtb inhibition activity Total score 
W. score (50%) W. score (25%) W. score (25%) 
North Sumatera T. minangkabau 0.5 1.75 - 2.25 
North Sumatera  S. moorei 6.0 0.50 1.50 8.00 
Banten T. laeviceps 6.5 0.25 0.25 7.00 
West Java T. laeviceps 3.0 1.25 0.75 5.00 
Central Java T. laeviceps 4.5 1.50 1.00 7.00 
West Kalimantan H. itama 5.0 2.50 0.50 8.00 
East Kalimantan H. itama 1.0 1.00 1.25 3.25 
South Kalimantan H. itama 2.0 0.75 0.75 3.50 
South Kalimantan T. laeviceps 2.5 2.75 - 5.25 
South Kalimantan  G. thorasica 1.5 3.50 2.00 7.00 
South Sulawesi G. incisa 7.0 3.00 1.75 11.75 
South Sulawesi  T. biroi 4.0 2.25 2.25 8.50 
West Nusa Tenggara T. fuscobalteata 3.5 2.00 2.25 7.75 
North Maluku T. fuscobalteata 5.5 3.25 0.50 9.25 
Based on these three test parameters, G. incisa propolis from South Sulawesi Province was chosen as the best candidate of complementary 
nutraceutical of ATD. It had the following characteristics: 1) had the strongest potential to reduce the hepatotoxic effects of ATD, 2) had low toxicity 
potential, and 3) had strong potential to inhibit Mtb infection. 
 
CONCLUSION 
Based on the antioxidant capacity test, the highest score was owned 
by G. incisa propolis from South Sulawesi Province. The toxicity test 
indicated that G. thorasica propolis from South Kalimantan Province 
had the lowest toxicity. Furthermore, Mtb H37Rv inhibition test 
showed that the highest score was achieved by T. biroi propolis from 
South Sulawesi Province and T. fuscobalteata propolis from West 
Nusa Tenggara Province. Based on all test parameters, the highest 
score was achieved by G. incisa propolis from South Sulawesi 
Province. Thus, it was defined as ATD complementary nutraceutical 
candidate. Further studies on animal models and clinical studies are 
needed to establish this propolis as the complementary 
nutraceutical of ATD. 
Sulaeman et al. 
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